Press release
DDR Defective Tumors Market is expected to reach US$ 12.4 billion by 2032 | Major players - AstraZeneca, Novartis AG, Chordia Therapeutics Inc., F. Hoffmann-La Roche Ltd
DDR Defective Tumors Market
The Global DDR Defective Tumors Market size reached US$ 8.0 billion in 2024 and is expected to reach US$ 12.4 billion by 2032, growing at a CAGR of 7.0% during the forecast period 2025-2032.
The DDR Defective Tumors Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/ddr-defective-tumors-market?sz
The DDR (DNA Damage Response) Defective Tumors Market focuses on therapies and diagnostics targeting tumors with impaired DNA repair mechanisms. These defects make cancer cells more susceptible to targeted treatments like PARP inhibitors. The market encompasses drug development, companion diagnostics, and personalized oncology solutions, driven by rising cancer prevalence, advances in precision medicine, and increasing adoption of biomarker-driven therapies globally.
Recent Key Developments of United States:
✅ December 2025: Launch of a nationwide biomarker testing initiative enhanced DDR profiling in solid tumors, accelerating patient stratification for targeted treatments.
✅ November 2025: Major clinical trial results from a Phase III study on ATR inhibitors showed improved progression-free survival in prostate cancers with DDR defects, driving investor interest.
✅ October 2025: FDA expanded approval for a next-generation PARP inhibitor targeting BRCA-mutated ovarian cancers in DDR-defective tumors, boosting market access for precision therapies.
Recent Key Developments of Japan:
✅ December 2025: Expansion of genomic screening programs in key oncology centers improved detection rates of DDR mutations, supporting uptake of imported PARP inhibitors.
✅ November 2025: Collaborative research between Japanese pharma firms and US biotech advanced synthetic lethality combos for pancreatic DDR-defective tumors into late-stage trials.
✅ October 2025: PMDA approved a domestically developed WEE1 inhibitor for endometrial cancers with DDR pathway deficiencies, marking a milestone in local innovation.
List of the Key Players in the DDR Defective Tumors Market:
Artios Pharma Limited, Inc.
AstraZeneca
Aprea Therapeutics, Inc., Inc.
KSQ Therapeutics, Inc.
Pfizer, Inc.
F. Hoffmann-La Roche Ltd,
Novartis AG
DAIICHI SANKYO COMPANY, LIMITED.
Chordia Therapeutics Inc.
REPARE THERAPEUTICS
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ddr-defective-tumors-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the DDR Defective Tumors Market:
By Molecule Type: Biologics, Small Molecules.
By Cancer Type: Ovarian, Prostate, Breast, Pancreatic, Others.
By End User: Hospitals, Cancer Research Centers, Specialty Clinics.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=ddr-defective-tumors-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, DDR Defective Tumors market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global DDR Defective Tumors Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global DDR Defective Tumors market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the DDR Defective Tumors Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the DDR Defective Tumors Market in 2025?
◆ What is the projected growth rate of the DDR Defective Tumors Market through 2033?
◆ Who are the key players in the DDR Defective Tumors Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release DDR Defective Tumors Market is expected to reach US$ 12.4 billion by 2032 | Major players - AstraZeneca, Novartis AG, Chordia Therapeutics Inc., F. Hoffmann-La Roche Ltd here
News-ID: 4359746 • Views: …
More Releases from DataM Intelligence 4Market Research
Hemostatic Agents Market is expected to reach US$ 4.15 billion by 2032 | Major C …
Market Size and Growth:
The Global Hemostatic Agents Market size reached US$ 3.01 billion in 2024 and is expected to reach US$ 4.15 billion by 2032, growing at a CAGR of 4.2% during the forecast period 2025-2032.
The Hemostatic Agents Market refers to the global industry focused on products and materials designed to stop bleeding during surgical procedures, trauma, or emergency care. These agents include topical powders, dressings, foams, and gels that…
PARP Inhibitors Market is expected to reach US$ 6.64 billion by 2031 | Major Com …
Market Size and Growth:
The Global PARP Inhibitors Market size reached US$ 3.53 billion in 2023 and is expected to reach US$ 6.64 billion by 2031, growing at a CAGR of 8.3% during the forecast period 2024-2031.
The PARP inhibitors Market refers to the global industry focused on developing, manufacturing, and commercializing drugs that inhibit poly (ADP-ribose) polymerase (PARP) enzymes. These targeted therapies are primarily used in oncology to treat cancers with…
Voice Assistant Market is expected to reach US$ 14.20 billion by 2032 | Major Co …
Market Size and Growth:
The Global Voice Assistant Market size reached US$ 2.73 billion in 2024 and is expected to reach US$ 14.20 billion by 2032, growing with a CAGR of 22.89% during the forecast period 2025-2032.
The Voice Assistant Market refers to the global industry focused on the development, production, and adoption of software and devices that enable users to interact with technology through voice commands. It includes smart speakers, smartphones,…
Gluten-Free Products Market is expected to reach USD 9.6 billion by 2031 | Major …
Market Size and Growth:
The Global Gluten-Free Products Market size reached USD 5.7 billion in 2022 and is expected to reach USD 9.6 billion by 2031, growing with a CAGR of 6.8% during the forecast period 2024-2031.
The Gluten-Free Products Market refers to the global industry focused on manufacturing, distributing, and retailing food and beverage items formulated without gluten-a protein found in wheat, barley, and rye. This market serves individuals with…
More Releases for DDR
2026 DDR Memory Market Core Forecast
In 2026, the DDR memory market enters a supply-driven structural super cycle, with a supply-demand gap of 7.1%, most prominent in the server segment. A fundamental shift in demand structure occurs: the server sector accounts for 45% of the market, as AI server memory consumption surges by 40%-50% year-on-year, making high-density DDR5 the core growth driver. Meanwhile, the PC segment holds only a 10% share, and mobile DRAM growth slows…
DDR-Defective Tumors Market New Product Development & Latest Trends
Introduction
DNA Damage Response (DDR) pathways are critical for maintaining genome integrity. When these pathways are defective, mutations accumulate, leading to tumor development. DDR-defective tumors are cancers associated with impaired DNA repair mechanisms, often linked to mutations in BRCA1, BRCA2, ATM, CHEK2, PALB2, and related genes. Such defects are common in breast, ovarian, prostate, and pancreatic cancers, among others.
Targeting DDR pathways has become one of the most exciting frontiers in oncology.…
Global DDR PMIC Market Size, Share & Forecast 2025-2031
Unlock the Future of the DDR PMIC Market: Comprehensive Global Market Report 2025-2031
Global leading market research publisher QYResearch published the release of its latest report, "DDR PMIC - Global Market Share, Ranking, Sales, and Demand Forecast 2025-2031". This in-depth report provides a complete analysis of the global DDR PMIC market, offering critical insights into market size, share, demand, industry development status, and future forecasts. Whether you're a stakeholder, investor, or…
Mobile Ddr Market to Exhibit 11.73% CAGR by 2032
The Mobile DDR Market has been experiencing rapid growth, driven by the increasing demand for high-performance memory solutions in mobile devices. In 2023, the market size was estimated at USD 45.05 billion, underscoring the crucial role that Mobile DDR plays in powering smartphones, tablets, and other portable electronic devices. Mobile DDR technology is essential for enhancing the speed, efficiency, and battery life of these devices, making it a cornerstone of…
DDR Defective Tumors Market Report 2032 | DelveInsight
DelveInsight's "DDR Defective Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DDR Defective Tumors, historical and forecasted epidemiology as well as the DDR Defective Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The DDR Defective Tumors market report provides current treatment practices, emerging drugs, DDR Defective Tumors market share of the individual therapies, and current…
Latest Trends In Global DDR Memory Power IC Market
A DDR memory power IC, sometimes referred to as a DDR memory power management integrated circuit, is an essential part of computer systems that control DDR memory modules.
It is essential for supplying the required power and voltage regulation to guarantee the steady and dependable operation of DDR memory modules.
DDR memory power ICs are in charge of managing and controlling the power supply to the memory modules, making sure they…
